Key result
QSAR models based on simplex representation successfully predicted CC50, IC50, and SI values for [(biphenyloxy)propyl]isoxazole derivatives against human rhinovirus 2.
QSAR models successfully predicted the antiviral activity of [(biphenyloxy)propyl]isoxazole derivatives against human rhinovirus 2, leading to the design of three new active compounds.
Answers are grounded in this paper and cite their sources.
May accelerate preclinical antiviral screening; leaves open clinical translation pending human trials.
The 50% cytotoxic concentration (CC50) in HeLa cells, the 50% inhibitory concentration (IC50) against human rhinovirus 2 (HRV-2), and the selectivity index (SI = CC50/IC50) of [(biphenyloxy)propyl]isoxazole derivatives were used to develop quantitative structure-activity relationships (QSAR) based on simplex representation of molecular structure. Statistic characteristics for partial least-squares models are quite satisfactory (R2 = 0.838 - 0.918; Q2 = 0.695 - 0.87) for prediction of CC50, IC50, and SI values and permit the virtual screening and molecular design of new compounds with strong anti-HRV-2 activity. The quality of prognosis for designed compounds was additionally estimated by analysis of domain applicability for each QSAR model. A hypothesis to the effect that terminal benzene substituents must have negative electrostatic potential and definite length (approximately 5.5-5.6 A) to possess strong antiviral activity has been suggested. The quality of developed analysis, i.e., high level of antiviral action of three new designed compounds, has been confirmed experimentally.
No takes yet. Share an insight, caveat, or question.
Kuz’min et al. (2007) studied Human rhinovirus 2 (HRV-2) infection. [(biphenyloxy)propyl]isoxazole derivatives was evaluated on 50% cytotoxic concentration (CC50), 50% inhibitory concentration (IC50), and selectivity index (SI). QSAR models based on simplex representation successfully predicted CC50, IC50, and SI values for [(biphenyloxy)propyl]isoxazole derivatives against human rhinovirus 2.
Synapse has enriched 10 related papers. Consider them for comparative context: